Form 8-K - Current report:
SEC Accession No. 0001558370-21-017044
Filing Date
2021-12-28
Accepted
2021-12-28 16:11:23
Documents
15
Period of Report
2021-12-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20211223x8k.htm   iXBRL 8-K 39625
2 EX-10.1 ganx-20211223xex10d1.htm EX-10.1 146606
3 EX-10.2 ganx-20211223xex10d2.htm EX-10.2 75898
4 EX-99.1 ganx-20211223xex99d1.htm EX-99.1 9049
  Complete submission text file 0001558370-21-017044.txt   441257

Data Files

Seq Description Document Type Size
5 EX-101.SCH ganx-20211223.xsd EX-101.SCH 3060
6 EX-101.LAB ganx-20211223_lab.xml EX-101.LAB 18080
7 EX-101.PRE ganx-20211223_pre.xml EX-101.PRE 10629
9 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20211223x8k_htm.xml XML 5085
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 211525073
SIC: 2834 Pharmaceutical Preparations